Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus

Table 1

Clinical characteristics of systemic lupus erythematosus (SLE) patients.

	SLE	Controls
Sex (F/M)	32/2	32/2
Age (years, mean ± SD)	35.2 ± 2.1	33.6 ± 3.3
Disease duration (years)	4.47 ± 1.3
Treatment
Methotrexate	21
Prednisone	22
Antimalarials	16
Mycophenolate	5
Azathioprine	4
Cyclosporine	2
SLEDAI (mean ± SD)	5.9 ± 0.8
SLEDAI ≥ 8	12
SLEDAI ≤ 8	20

Dosage: methotrexate 12.5–20 mg/week; prednisone 5–10 mg/day; chloroquine 150–300 mg/day; azathioprine 100 mg/day; mycophenolate mofetil 2 g/day; and cyclosporine 50–100 mg/day weight adjusted.